A novel mechanism for GABA synthesis and packaging into synaptic vesicles

Neurochemistry International

Volumn 55, Issue 1-3, 2009, Pages 9-12

  Buddhala, Chandana ^a   Hsu, Che Chang ^a   Wu, Jang Yen ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

GABA synthesis and packaging; GAD65; Mitochondria; Regulation; Synaptic vesicles

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; VESICULAR INHIBITORY AMINO ACID TRANSPORTER;

ARTICLE; BRAIN; DECARBOXYLATION; DEGENERATIVE DISEASE; HUMAN; MITOCHONDRION; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SYNAPSE VESICLE; TRANSCRIPTION REGULATION;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE DECARBOXYLASE; HUMANS; MITOCHONDRIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 64949134655     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.01.020     Document Type: Article

References (52)

1. Balasa B., Boehm B.O., Fortnagel A., Karges W., Van Gunst K., Jung N., Camacho S.A., Webb S.R., and Sarvetnick N. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. Clin. Immunol. Orlando, FL 99 (2001) 241-252
2. Battaglioli G., Liu H., and Martin D.L. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J. Neurochem. 86 (2003) 879-887
3. Behar T., Schaffner A., Laing P., Hudson L., Komoly S., and Barker J. Many spinal cord cells transiently express low molecular weight forms of glutamic acid decarboxylase during embryonic development. Brain Res. 72 (1993) 203-218
4. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., and Tobin A.J. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2115-2119
5. Burbelo P.D., Groot S., Dalakas M.C., and Iadarola M.J. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem. Biophys. Res. Commun. 366 (2008) 1-7
6. Butler M.H., Solimena M., Dirkx Jr. R., Hayday A., and De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 178 (1993) 2097-2106
7. Chu W.C., and Metzler D.E. Enzymatically active truncated cat brain glutamate decarboxylase: expression, purification, and absorption spectrum. Arch. Biochem. Biophys. 313 (1994) 287-295
8. Dass B., Olanow C.W., and Kordower J.H. Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease. Neurology 66 (2006) S89-103
9. de Graauw M., Hensbergen P., and van de Water B. Phospho-proteomic analysis of cellular signaling. Electrophoresis 27 (2006) 2676-2686
10. de Jong P.J., Lakke J.P., and Teelken A.W. CSF GABA levels in Parkinson's disease. Adv. Neurol. 40 (1984) 427-430
11. Fenalti G., Law R.H., et al. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat. Struct. Mol. Biol. 14 (2007) 280-286
12. Freichel C., Potschka H., Ebert U., Brandt C., and Loscher W. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience 141 (2006) 2177-2194
13. Gourfinkel-An I., Parain K., Hartmann A., Mangiarini L., Brice A., Bates G., and Hirsch E.C. Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice. J. Neurochem. 86 (2003) 1369-1378
14. Grattan D.R., Rocca M.S., Strauss K.I., Sagrillo C.A., Selmanoff M., and McCarthy M.M. GABAergic neuronal activity and mRNA levels for both forms of glutamic acid decarboxylase (GAD65 and GAD67) are reduced in the diagonal band of Broca during the afternoon of proestrus. Brain Res. 733 (1996) 46-55
15. Heldt S.A., Green A., and Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29 (2004) 1610-1619
16. Hsu C.C., Thomas C., et al. Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase. J. Biol. Chem. 274 (1999) 24366-24371
17. Jin H., Wu H., et al. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4293-4298
18. Kanaani J., Diacovo M.J., El-Husseini Ael D., Bredt D.S., and Baekkeskov S. Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters. J. Cell Sci. 117 (2004) 2001-2013
19. Kanaani J., Patterson G., Schaufele F., Lippincott-Schwartz J., and Baekkeskov S. A palmitoylation cycle dynamically regulates partitioning of the GABA-synthesizing enzyme GAD65 between ER-Golgi and post-Golgi membranes. J. Cell Sci. 121 (2008) 437-449
20. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., and Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14060-14065
21. Kaufman D.L., Houser C.R., and Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56 (1991) 720-723
22. Kosel M., Rudolph U., Wielepp P., Luginbuhl M., Schmitt W., Fisch H.U., and Schlaepfer T.E. Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety. Neuropsychopharmacology 29 (2004) 347-350
23. Lamigeon C., Bellier J.P., Sacchettoni S., Rujano M., and Jacquemont B. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J. Neurochem. 77 (2001) 598-606
24. Laprade N., and Soghomonian J.J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res. Mol. Brain Res. 34 (1995) 65-74
25. Laprade N., and Soghomonian J.J. MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 6 (1995) 1885-1889
26. Li A.F., and Escher A. Intradermal or oral delivery of GAD-encoding genetic vaccines suppresses type 1 diabetes. DNA Cell Biol. 22 (2003) 227-232
27. Liu W., Liu Z., et al. A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury. Neurosci. Lett. 432 (2008) 13-18
28. Lloyd K.G., Bossi L., Morselli P.L., Munari C., Rougier M., and Loiseau H. Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv. Neurol. 44 (1986) 1033-1044
29. Luo J., Kaplitt M.G., Fitzsimons H.L., Zuzga D.S., Liu Y., Oshinsky M.L., and During M.J. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 298 (2002) 425-429
30. Martin D.L., and Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60 (1993) 395-407
31. McLaughlin B.J., Wood J.G., Saito K., Roberts E., and Wu J.Y. The fine structural localization of glutamate decarboxylase in developing axonal processes and presynaptic terminals of rodent cerebellum. Brain Res. 85 (1975) 355-371
32. Namchuk M., Lindsay L., Turck C.W., Kanaani J., and Baekkeskov S. Phosphorylation of serine residues 3, 6, 10 and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha. J. Biol. Chem. 272 (1997) 1548-1557
33. Opolski A., Mazurkiewicz M., Wietrzyk J., Kleinrok Z., and Radzikowski C. The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J. Exp. Clin. Cancer Res. 19 (2000) 383-390
34. Pinal C.S., and Tobin A.J. Uniqueness and redundancy in GABA production. Perspect. Dev. Neurobiol. 5 (1998) 109-118
35. Rimvall K., and Martin D.L. The level of GAD67 protein is highly sensitive to small increases in intraneuronal gamma-aminobutyric acid levels. J. Neurochem. 62 (1994) 1375-1381
36. Schmidli R.S., Faulkner-Jones B.E., Harrison L.C., James R.F., and DeAizpurua H.J. Cytokine regulation of glutamate decarboxylase biosynthesis in isolated rat islets of Langerhans. Biochem. J. 317 Pt 3 (1996) 713-719
37. Sha D., Jin Y., et al. Role of mu-calpain in proteolytic cleavage of brain l-glutamic acid decarboxylase. Brain Res. 1207 (2008) 9-18
38. Sha D., Wei J., Wu H., Jin Y., and Wu J.Y. Molecular cloning, expression, purification, and characterization of shorter forms of human glutamic decarboxylase 67 in an E. coli expression system. Brain Res. Mol. Brain Res. 136 (2005) 255-261
39. Somogyi R., Wen X., Ma W., and Barker J.L. Developmental kinetics of GAD family mRNAs parallel neurogenesis in the rat spinal cord. J. Neurosci. 15 (1995) 2575-2591
40. Spokes E.G., Garrett N.J., Rossor M.N., and Iversen L.L. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. J. Neurol. Sci. 48 (1980) 303-313
41. Stork O., Yamanaka H., Stork S., Kume N., and Obata K. Altered conditioned fear behavior in glutamate decarboxylase 65 null mutant mice. Genes Brain Behav. 2 (2003) 65-70
42. Tillakaratne N.J., Medina-Kauwe L., and Gibson K.M. Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp. Biochem. Physiol. A Physiol. 112 (1995) 247-263
43. Waagepetersen H.S., Sonnewald U., Gegelashvili G., Larsson O.M., and Schousboe A. Metabolic distinction between vesicular and cytosolic GABA in cultured GABAergic neurons using 13C magnetic resonance spectroscopy. J. Neurosci. Res. 63 (2001) 347-355
44. Waagepetersen H.S., Sonnewald U., and Schousboe A. The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J. Neurochem. 73 (1999) 1335-1342
45. Watanabe M., Maemura K., Kanbara K., Tamayama T., and Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int. Rev. Cytol. 213 (2002) 1-47
46. Wei J., Davis K.M., Wu H., and Wu J.Y. Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications. Biochemistry 43 (2004) 6182-6189
47. Wei J., Jin Y., Wu H., Sha D., and Wu J.Y. Identification and functional analysis of truncated human glutamic acid decarboxylase 65. J. Biomed. Sci. 10 (2003) 617-624
48. Wei J., Lin C.H., Wu H., Jin Y., Lee Y.H., and Wu J.Y. Activity-dependent cleavage of brain glutamic acid decarboxylase 65 by calpain. J. Neurochem. 98 (2006) 1688-1695
49. Wei J., and Wu J.Y. Structural and functional analysis of cysteine residues in human glutamate decarboxylase 65 (GAD65) and GAD67. J. Neurochem. 93 (2005) 624-633
50. Wei J., and Wu J.Y. Post-translational regulation of l-glutamic acid decarboxylase in the brain. Neurochem. Res. (2008)
51. Wu H., Jin Y., et al. Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles-evidence from GAD65-knockout mice studies. Brain Res. 1154 (2007) 80-83
52. Wu J.Y., and Roberts E. Properties of brain l-glutamate decarboxylase: inhibition studies. J. Neurochem. 23 (1974) 759-767